SC
NVO

Solstein Capital’s Novo Nordisk NVO Stock Holding History

Solstein Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.1K Hold
794
– – 0.01% 248
2026
Q1 		$29.2K Hold
794
– – 0.01% 264
2025
Q4 		$40.4K Hold
794
– – 0.02% 226
2025
Q3 		$44.1K Sell
794
-14,483
-95% -$848K 0.01% 213
2025
Q2 		$1.05M Hold
15,277
– – 0.54% 45
2025
Q1 		$1.06M Sell
15,277
-5,560
-27% -$459K 0.62% 40
2024
Q4 		$1.79M Sell
20,837
-5,000
-19% -$541K 1% 23
2024
Q3 		$3.08M Sell
25,837
-5,000
-16% -$667K 1.63% 13
2024
Q2 		$4.4M Hold
30,837
– – 2.87% 6
2024
Q1 		$3.96M Sell
30,837
-921
-3% -$110K 2.75% 7
2023
Q4 		$3.29M Buy
31,758
+28
+0.1% +$2.77K 2.43% 9
2023
Q3 		$2.89M Hold
31,730
– – 2.48% 9
2023
Q2 		$2.57M Buy
31,730
+380
+1% +$31K 2.14% 12
2023
Q1 		$2.49M Sell
31,350
-2,290
-7% -$162K 2.17% 13
2022
Q4 		$2.28M Sell
33,640
-3,528
-9% -$207K 1.9% 13
2022
Q3 		$1.85M Buy
37,168
+288
+0.8% +$15.4K 1.63% 14
2022
Q2 		$2.06M Buy
36,880
+386
+1% +$21.4K 1.57% 13
2022
Q1 		$2.03M Sell
36,494
-1,088
-3% -$55.8K 1.33% 19
2021
Q4 		$2.1M Sell
37,582
-782
-2% -$42.4K 1.27% 18
2021
Q3 		$1.84M Buy
38,364
+25,520
+199% +$1.23M 1.06% 23
2021
Q2 		$538K Sell
12,844
-90
-0.7% -$3.49K 0.66% 45
2021
Q1 		$436K Buy
12,934
+2,760
+27% +$98.3K 0.59% 55
2020
Q4 		$356K Buy
10,174
+1,054
+12% +$36.4K 0.15% 56
2020
Q3 		$317K Sell
9,120
-1,800
-16% -$60K 0.71% 41
2020
Q2 		$358K Buy
+10,920
New +$348K 0.85% 35

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Solstein Capital's NVO Position: Q2 2026 in Review

Solstein Capital held its Novo Nordisk (NVO) position steady in Q2 2026 at 794 shares worth $38.1K. The position accounts for 0.01% of the portfolio, ranked #248.

Solstein Capital first reported a position in NVO in Q2 2020 and has held it in 25 quarters since. The position peaked at $4.4M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Solstein Capital held 794 shares of Novo Nordisk worth $38.1K as of Q2 2026.
  • Solstein Capital left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.01% of Solstein Capital's portfolio in Q2 2026, its #248 holding.
  • Solstein Capital first reported a position in Novo Nordisk in Q2 2020 and has held it in 25 quarters since.
  • Solstein Capital's Novo Nordisk position peaked at $4.4M in Q2 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Solstein Capital's 13F filing for Q2 2026, filed 13 Aug 2026.